Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Remicade Market In 2029?
The significant expansion of the Remicade market size has been observed recently. The market is projected to surge from $2514.05 million in 2024 to $2656.87 million in 2025, reflecting a compound annual growth rate (CAGR) of 5.7%. The historical growth can be credited to factors such as the rise in autoimmune diseases, broader acceptance and application of biologic treatments, advances in healthcare infrastructure, the period of patent exclusivity, and proven clinical effectiveness.
What Growth Rate Is Forecasted for the Remicade Market by 2029?
Expectations are high for the remicade market to experience robust growth in the coming years, with projected growth up to $3268.05 million in 2029 at a Compound Annual Growth Rate (CAGR) of 5.3%. Several factors that may contribute to the growth during the anticipated period include increased presence of biosimilars, global disease burden, expanding markets in emerging economies, regulatory and insurance backing, and a rise in discretionary income. The forecasted period is also set to show significant trends such as the adoption of biosimilars, the integration of digital health, the progression of personalized medicine, innovations in biologic treatments, and advancements in drug delivery systems.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20194&type=smp
Which Key Companies Are Shaping the Future of the Remicade Market?
Major companies operating in the remicade market include Janssen Biotech Inc.
Which Factors Are Driving Demand in the Remicade Industry?
The escalating rates of autoimmune diseases are anticipated to propel the remicade market’s growth. The immune system mistakenly attacking the body’s own healthy cells, tissues, or organs underpins autoimmune diseases, falsely identifying them as alien threats. Increased exposure to pollutants, genetic susceptibility, environmental alterations, lifestyle aspects, and heightened diagnostic awareness contribute to the escalating occurrence of autoimmune diseases. Remicade (infliximab) proves valuable in managing autoimmune diseases by impeding tumor necrosis factor-alpha (TNF-a), a significant inflammatory cytokine implicated in ailments such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis. For instance, the Centers for Disease Control and Prevention (CDC), an American national public health institute, indicated in February 2024 that the age-adjusted prevalence of diagnosed arthritis among adults aged 18 and older was 18.9% in 2022, with women (21.5%) reporting higher incidence rates than men (16.1%). Arthritis prevalence grew with age, with a range from 3.6% in individuals aged 18–34 to 53.9% in those aged 75 and above. Thus, the escalating rates of autoimmune diseases are fueling the remicade market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=20194&type=smp
How Is the Remicade Market Segmented by Several Divisions?
The remicade market covered in this report is segmented –
1) By Disease Indication: Crohn’s disease, Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic arthritis, Ulcerative Colitis, Plaque psoriasis
2) By Route Of Administration: Subcutaneous, Intravenous, Parenteral
3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care
What are the Emerging Market Trends Driving the Growth of the Remicade Industry?
One prominent development in the remicade market is the increasing emphasis on drug formulation innovation, specifically the creation of subcutaneous versions of drugs. Such advancements enhance patient compliance with treatments, improve market reach by providing a simpler and quicker option compared to traditional IV treatments. As an example, Celltrion USA, Inc., a biopharmaceutical company based in the US, in March of 2024, introduced Zymfentra, the first FDA approved subcutaneous formulation of infliximab. Zymfentra (infliximab-dyyb) is recommended as a regular treatment for adults suffering from moderate-to-severe active ulcerative colitis (UC) and Crohn’s disease (CD), both conditions collectively known as inflammatory bowel disease (IBD). The approval of Zymfentra provides a more convenient choice for prolonged disease control after initial treatment with an intravenous infliximab product.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/remicade-global-market-report
Which Regions Are Driving Growth in the Remicade Market?
North America was the largest region in the remicade market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remicade market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20194
This Report Delivers Insight On:
1. How big is the remicade market, and how is it changing globally?
2. Who are the major companies in the remicade market, and how are they performing?
3. What are the key opportunities and risks in the remicade market right now?
4. Which products or customer segments are growing the most in the remicade market?
5. What factors are helping or slowing down the growth of the remicade market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model